Women’s Health Dialogue; Public Meeting

---
identifier: "/us/fr/01-8201"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Women’s Health Dialogue; Public Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "01-8201"
section_name: "Women’s Health Dialogue; Public Meeting"
positive_law: false
currency: "2001-04-04"
last_updated: "2001-04-04"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "01-8201"
document_type: "notice"
publication_date: "2001-04-04"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "66 FR 17912"
fr_volume: 66
fr_action: "Notice of meeting."
---


#  Women’s Health Dialogue; Public Meeting

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice of meeting.

The Food and Drug Administration's (FDA) Office of Women’s Health is announcing the following meeting: Women’s Health Dialogue. The topics to be discussed are: Women in clinical trials, product safety, and consumer education and outreach.

*Date and Time* : The meeting will be held on April 18, 2001, from 10:30 a.m. to 5:30 p.m.

*Location* : Humbert Humphrey Bldg., 200 Independence Ave. NW., Washington, DC.

*Contact* : Gwen Jones, Office of Women’s Health, 301-827-3369, FAX: 301-827-0926. Space is limited. Please contact Gwen Jones by April 13, 2001.

If you need special accommodations due to a disability, please contact Gwen Jones at least 7 days in advance.

Dated: March 29, 2001.

William K. Hubbard,

Senior Associate Commissioner for Policy, Planning, and Legislation.